Stock ScreenerStock IdeasBiotech BreakthroughsBest Biotech Stocks To Buy NowTop biotech stocks that analysts expect to be profitable within the next 3 years
Stock ScreenerStock IdeasBiotech Breakthroughs
Industry: Biotechnology
Forecast Earnings Growth: Positive
| Ticker | Company | Zen Rating | Price | Value | Graham Fair Value | Graham Fair Value % | P/E | Forward P/E | P/S | P/B | PEG | Free Cash Flow | Free Cash Flow Yield | Book Value | BVPS | EV | EV/EBITDA |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| PGEN | PRECIGEN INC | $4.72 | $4.37 | 8.03% | 36.31x | 19.67x | 10.78x | 20.20x | 0.38x | -$74.32M | -4.39% | $83.79M | 0.23 | $1.78B | 43.45 | ||
| CORT | CORCEPT THERAPEUTICS INC | $74.53 | $40.49 | 84.06% | 49.36x | 35.10x | 8.25x | 9.78x | 0.68x | $194.62M | 2.45% | $833.74M | 7.82 | $8.07B | 72.73 | ||
| TGTX | TG THERAPEUTICS INC | $65.76 | $20.88 | 214.98% | 84.31x | 64.15x | 10.31x | 17.37x | 1.17x | $85.56M | 0.92% | $572.13M | 4.06 | $10.26B | 52.27 | ||
| RPRX | ROYALTY PHARMA PLC | $70.01 | $35.70 | 96.09% | 45.76x | 12.80x | 11.93x | 4.10x | 0.75x | $2.89B | 9.27% | $9.80B | 21.96 | $48.23B | 46.22 | ||
| LGND | LIGAND PHARMACEUTICALS INC | $316.83 | $74.40 | 325.85% | 119.56x | 32.67x | 24.92x | 6.59x | 1.56x | $90.43M | 1.43% | $961.76M | 48.18 | $7.43B | 75.50 | ||
| ARQT | ARCUTIS BIOTHERAPEUTICS INC | $28.38 | $8.14 | 248.69% | 129.00x | 91.61x | 7.31x | 14.71x | 1.22x | $59.71M | 1.61% | $243.97M | 1.86 | $3.67B | 78.43 | ||
| KRYS | KRYSTAL BIOTECH INC | $308.81 | $78.65 | 292.62% | 40.31x | 39.41x | 19.45x | 6.37x | 2.23x | $310.08M | 3.39% | $1.44B | 48.48 | $8.70B | 32.75 | ||
| KNSA | KINIKSA PHARMACEUTICALS INTERNATIONAL PLC | $95.76 | $14.87 | 543.95% | 66.97x | 72.97x | 7.92x | 10.59x | 3.62x | $197.20M | 2.63% | $710.19M | 9.08 | $7.45B | 49.01 | ||
| ADMA | ADMA BIOLOGICS INC | $13.19 | $7.04 | 87.39% | 16.70x | 16.37x | 5.68x | 6.67x | 1.23x | $132.91M | 4.50% | $438.51M | 1.96 | $3.00B | 11.87 | ||
| HALO | HALOZYME THERAPEUTICS INC | $101.68 | $76.26 | 33.34% | 23.98x | 11.23x | 6.42x | -209.86x | 0.55x | $885.88M | 7.66% | -$55.24M | -0.49 | $13.81B | 17.14 | ||
| VCEL | VERICEL CORP | $59.45 | $8.69 | 583.92% | 90.08x | 78.76x | 9.39x | 7.90x | 3.27x | $57.89M | 1.90% | $384.17M | 7.51 | $2.99B | 55.46 | ||
| JAZZ | JAZZ PHARMACEUTICALS PLC | $248.24 | $133.09 | 86.52% | 68.20x | 16.25x | 3.40x | 3.80x | 0.65x | $1.65B | 10.29% | $4.19B | 64.79 | $19.53B | 17.04 | ||
| INCY | INCYTE CORP | $122.27 | $54.28 | 125.27% | 58.50x | 35.43x | 4.13x | 4.42x | 0.84x | $684.87M | 2.76% | $5.64B | 27.76 | $21.68B | 24.17 | ||
| EXEL | EXELIXIS INC | $70.70 | $32.16 | 119.86% | 20.49x | 20.19x | 6.99x | 9.41x | 1.37x | $1.16B | 6.65% | $1.83B | 7.43 | $17.11B | 15.31 | ||
| TECH | BIO-TECHNE CORP | $72.80 | $16.46 | 342.31% | 66.18x | 35.05x | 9.29x | 5.28x | 1.98x | $308.20M | 2.70% | $2.17B | 13.81 | $11.37B | 34.07 | ||
| VRTX | VERTEX PHARMACEUTICALS INC | $547.03 | $148.18 | 269.17% | 34.91x | 29.43x | 10.71x | 6.63x | 2.27x | $3.20B | 2.31% | $20.91B | 82.48 | $140.19B | 27.84 | ||
| ZVRA | ZEVRA THERAPEUTICS INC | $11.85 | $8.08 | 46.71% | 9.33x | 10.37x | 4.76x | 2.95x | 1.79x | $87.07M | 12.37% | $238.92M | 4.02 | $584.21M | 6.08 | ||
| CYPH | CYPHERPUNK TECHNOLOGIES INC | $2.00 | $6.45 | -68.98% | 3.39x | -49.02x | N/A | 1.55x | 0.17x | -$21.06M | -5.70% | $139.32M | 0.76 | $207.91M | 165.40 | ||
| HRMY | HARMONY BIOSCIENCES HOLDINGS INC | $34.22 | $28.88 | 18.50% | 11.07x | 8.92x | 2.02x | 1.87x | 0.74x | $322.93M | 16.16% | $1.07B | 18.36 | $1.51B | 5.57 | ||
| UTHR | UNITED THERAPEUTICS CORP | $595.66 | $214.63 | 177.53% | 20.85x | 22.25x | 7.98x | 4.04x | 2.32x | $867.20M | 3.41% | $6.28B | 146.98 | $24.18B | 14.97 | ||
| REGN | REGENERON PHARMACEUTICALS INC | $959.41 | $498.65 | 92.40% | 20.41x | 13.66x | 5.77x | 2.96x | 1.07x | $3.83B | 3.92% | $33.50B | 329.39 | $98.30B | 15.74 | ||
| VCYT | VERACYTE INC | $25.11 | $9.85 | 154.87% | 15.79x | 12.82x | 3.47x | 1.41x | 3.38x | $161.95M | 8.01% | $1.43B | 17.80 | $1.87B | 13.08 |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.